Comparative effectiveness research

Scholarly Publications

Epidemiology, Causes, Clinical Manifestation and Diagnosis, Prevention and Control of Coronavirus Disease (COVID-19) During the Early Outbreak Period: A Scoping Review

March 2020

Background The coronavirus disease (COVID-19) has been identified as the cause of an outbreak of respiratory illness in Wuhan, Hubei Province, China beginning in December 2019.

Anesthesia Care Team Composition and Surgical Outcomes

August 2018

The adjusted mortality for care teams with anesthesiologist assistants was 1.6% (95% CI, 1.4 to 1.8) versus 1.7% for care teams with nurse anesthetists (95% CI, 1.7 to 1.7; difference −0.08; 95% CI...

Poverty and Community-Acquired Antimicrobial Resistance with Extended-Spectrum β-Lactamase–Producing Organisms, Hyderabad, India

August 2018

The decreasing effectiveness of antimicrobial agents is a global public health threat, yet risk factors for community-acquired antimicrobial resistance (CA-AMR) in low-income settings have not been...

Other Publications

Recommendations for Modeling Disaster Responses in Public Health and Medicine: A Position Paper of the Society for Medical Decision Making

July 2009

Purpose.

Comparative Effectiveness Research Prioritization

June 2009

Clinical research presents health care providers with information on the natural history and clinical presentations of disease as well as diagnostic and treatment options.

Maternal and Neonatal Outcomes of Elective Induction of Labor

March 2009

Background: Induction of labor is on the rise in the U.S., increasing from 9.5 percent in 1990 to 22.1 percent in 2004.

News

Examining the Value of Pharmacy Benefit Managers

March 2020

Most Americans don’t realize there are silent brokers helping to fix the price of their prescription drugs — or that it’s a $100 billion annual business accounting for half of Big Pharma sales.

Michelle Mello Answers Questions About the Federal Rollout of the Coronavirus Test

March 2020

We asked Stanford Health Policy's Michelle Mello — a professor of medicine and law — to answer some questions about the federal rollout of diagnostic testing for the coronavirus.

Task Force: Not Enough Evidence to Recommend Screening for Cognitive Impairment in Elderly

February 2020

More evidence-based research is needed before the U.S.

Events

Designing Policy using Modeling within Complex Socio-Technical Systems

December 1, 2011

Robert Glass, Jr. is the 2011-2012 Perry Fellow at CISAC.

The Health Policy Environment in Vietnam: Observations from an Outside Insider

February 25, 2010

The health sector's successes in Vietnam have been described as "legendary" by international donors, but there is always the other side of the story.

Safeguarding Uranium Enrichment Facilities

June 4, 2008

Nuclear energy production today and in the near future will still be dominated by light-water reactors and therefore there will be a continued need for uranium enrichment.

Multimedia

The Impact of Taiwan's National Health Insurance's 20-year Journey: How has the market responded and will respond?

September 2016

Audio and transcript from the Asia Health Policy Program seminar, "The Impact of Taiwan's National Health Insurance's 20-year Journey: How has the market responded and will respond?" on April 19, 2016, with Karen Eggleston,  Jui-fen Rachel Lu and...

Impact of China’s ‘Zero-markup Policy for Essential Drugs’ on Patients, County Hospital Revenue and Government Subsidy Levels

August 2016

Audio and transcript from the Asia Health Policy Program seminar "Impact of China’s ‘Zero-markup Policy for Essential Drugs’ on Patients, County Hospital Revenue and Government Subsidy Levels" on April 5, 2016, with Yanfang Su.China implemented a...

Trends in Disability in a Super-Aging Society: Adapting the Future Elderly Model to Japan

August 2016

Audio, transcript and presentation from the Asia Health Policy Program seminar "Trends in Disability in a Super-Aging Society: Adapting the Future Elderly Model to Japan" on Oct.